WAM
ARRY

Wolverine Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Wolverine Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$463K – 1741
2019
Q2 		$463K Buy
+10,000
New +$281K 0.01% 859
2019
Q1 		– Sell
-16,600
Closed -$236K – 1849
2018
Q4 		$236K Hold
16,600
– – ﹤0.01% 1211
2018
Q3 		$252K Hold
16,600
– – ﹤0.01% 1157
2018
Q2 		$278K Sell
16,600
-17,400
-51% -$277K ﹤0.01% 1056
2018
Q1 		$554K Sell
34,000
-187,400
-85% -$3M 0.01% 950
2017
Q4 		$2.83M Buy
221,400
+1,800
+0.8% +$20.5K 0.03% 414
2017
Q3 		$2.7M Hold
219,600
– – 0.03% 410
2017
Q2 		$1.84M Sell
219,600
-1,400
-0.6% -$11.4K 0.02% 464
2017
Q1 		$1.98M Buy
221,000
+1,100
+0.5% +$11.7K 0.03% 397
2016
Q4 		$1.93M Buy
219,900
+11,800
+6% +$86.8K 0.03% 408
2016
Q3 		$1.4M Buy
208,100
+54,300
+35% +$210K 0.02% 482
2016
Q2 		$547K Buy
153,800
+150,218
+4,194% +$490K 0.01% 687
2016
Q1 		$449K Buy
3,582
+950
+36% +$2.85K 0.01% 536
2015
Q4 		$239K Buy
2,632
+1,772
+206% +$8.09K 0.01% 814
2015
Q3 		$98K Sell
860
-1,436
-63% -$8.51K ﹤0.01% 1098
2015
Q2 		$113K Buy
2,296
+1,223
+114% +$9.03K ﹤0.01% 1076
2015
Q1 		$77K Sell
1,073
-264
-20% -$1.88K ﹤0.01% 1153
2014
Q4 		$30K Sell
1,337
-4,640
-78% -$18.4K ﹤0.01% 1543
2014
Q3 		$266K Buy
5,977
+5,738
+2,401% +$22.6K 0.01% 930
2014
Q2 		$18K Sell
239
-3,579
-94% -$14.8K ﹤0.01% 1720
2014
Q1 		$230K Buy
3,818
+1,529
+67% +$7.69K ﹤0.01% 832
2013
Q4 		$77K Sell
2,289
-4,574
-67% -$24.9K ﹤0.01% 1592
2013
Q3 		$211K Buy
+6,863
New +$40.8K ﹤0.01% 1143

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Wolverine Asset Management's ARRY Position: Q3 2019 in Review

Wolverine Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 82,346 shares — an estimated $3.81M sold.

Wolverine Asset Management first reported a position in ARRY in Q4 2018 and held it in 2 quarters. The position peaked at $3.81M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Wolverine Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Wolverine Asset Management sold 82,346 Array Biopharma Inc shares in Q3 2019, an estimated $3.81M.
  • Wolverine Asset Management first reported a position in Array Biopharma Inc in Q4 2018 and held it in 2 quarters.
  • Wolverine Asset Management's Array Biopharma Inc position peaked at $3.81M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Wolverine Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.